Chancery Awards $900K Fee For Biopharma Co. Settlement
A shareholder who negotiated a settlement with Sage Therapeutics Inc. after suing in Delaware Chancery Court over alleged "grossly excessive" director pay was awarded $900,000 for his efforts Tuesday, nearly three...To view the full article, register now.
Already a subscriber? Click here to view full article